Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 17401-17450 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT02911571
PRospective Multiple Myeloma Impact Study
NAActive, not recruiting
250 participants
Started: Feb 27, 2018 · Completed: Sep 1, 2026
1 condition2 sponsors9 locations
NCT03449953
Critical Care Outcomes of Hematologic Oncology Patients
N/AActive, not recruiting
415 participants
Started: Feb 26, 2018 · Completed: Dec 31, 2026
2 conditions1 sponsor13 locations
NCT03444454
Telerehabilitation in Multiple Sclerosis
NAActive, not recruiting
136 participants
Started: Feb 26, 2018 · Completed: Jun 30, 2024
1 condition6 sponsors1 location
NCT03460067
Omission of Radiation in Patients With Her-2 Positive Breast Cancer
NAActive, not recruiting
12 participants
Started: Feb 23, 2018 · Completed: Jul 16, 2027
1 condition1 sponsor1 location
NCT03405792
Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
PHASE2Active, not recruiting
40 participants
Started: Feb 23, 2018 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT03391362
Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases
NAActive, not recruiting
100 participants
Started: Feb 23, 2018 · Completed: Feb 1, 2026
2 conditions1 sponsor1 location
NCT03432949
Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC
PHASE4Active, not recruiting
24 participants
Started: Feb 23, 2018 · Completed: Jul 30, 2024
1 condition2 sponsors1 location
NCT03464305
ASPIRIN Trial Belgium
PHASE3Active, not recruiting
148 participants
Started: Feb 22, 2018 · Completed: Dec 31, 2027
1 condition3 sponsors29 locations
NCT04195139
Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
PHASE2Active, not recruiting
103 participants
Started: Feb 22, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors20 locations
NCT03092011
Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy
PHASE4Active, not recruiting
69 participants
Started: Feb 21, 2018 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT03631693
Imaging Analysis Following Periodontal Surgery
NAActive, not recruiting
60 participants
Started: Feb 21, 2018 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03525418
Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)
PHASE1/PHASE2Active, not recruiting
10 participants
Started: Feb 21, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT03299426
Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi
PHASE3Active, not recruiting
30,000 participants
Started: Feb 21, 2018 · Completed: Oct 30, 2025
1 condition5 sponsors1 location
NCT03436368
Continuous Spinal Anesthesia in Renal Transplantation
NAActive, not recruiting
60 participants
Started: Feb 20, 2018 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT03128268
The Effectiveness of 4D Image Acquisition and Post-processing With Vios Works
NAActive, not recruiting
250 participants
Started: Feb 20, 2018 · Completed: Jun 20, 2023
1 condition3 sponsors1 location
NCT03421132
Multiple Myeloma Molecular Monitoring Study
N/AActive, not recruiting
96 participants
Started: Feb 20, 2018 · Completed: Mar 31, 2026
1 condition1 sponsor9 locations
NCT03198026
Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas
PHASE2Active, not recruiting
30 participants
Started: Feb 20, 2018 · Completed: Feb 20, 2032
19 conditions3 sponsors1 location
NCT03532360
Peanut and Tree Nut Desensitization
NAActive, not recruiting
51 participants
Started: Feb 19, 2018 · Completed: Dec 31, 2027
2 conditions2 sponsors2 locations
NCT03285152
A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients
NAActive, not recruiting
19 participants
Started: Feb 19, 2018 · Completed: Aug 11, 2026
1 condition3 sponsors8 locations
NCT03384914
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
PHASE2Active, not recruiting
119 participants
Started: Feb 19, 2018 · Completed: Dec 31, 2027
8 conditions2 sponsors7 locations
NCT03437616
Cardiovascular Rehabilitation - Effectiveness of the Tulppa Program
NAActive, not recruiting
300 participants
Started: Feb 19, 2018 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT03395522
Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH
NAActive, not recruiting
149 participants
Started: Feb 18, 2018 · Completed: Apr 25, 2025
1 condition1 sponsor12 locations
NCT03491059
Feasibility of PET/CT to Detect the Oral/Pulmonary Distribution of Nicotine Following E-cigarette Use
PHASE4Active, not recruiting
2 participants
Started: Feb 16, 2018 · Completed: Feb 16, 2025
1 condition1 sponsor1 location
NCT03431181
Optimal VAsopressor TitraTION in Patients 65 Years and Older
NAActive, not recruiting
159 participants
Started: Feb 16, 2018 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT03441295
LIBRE (Ligamys, Internal Bracing, REconstruction) Study: Comparing Three Surgery Techniques After an Acute ACL Rupture.
NAActive, not recruiting
95 participants
Started: Feb 15, 2018 · Completed: Aug 30, 2025
1 condition3 sponsors3 locations
NCT03375437
RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.
NAActive, not recruiting
376 participants
Started: Feb 15, 2018 · Completed: Dec 15, 2025
3 conditions2 sponsors10 locations
NCT03138564
An Effectiveness-Implementation Trial of SPIRIT in ESRD
NAActive, not recruiting
852 participants
Started: Feb 15, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors39 locations
NCT03426748
LDR vs. HDR Brachytherapy for Prostate Cancer
NAActive, not recruiting
140 participants
Started: Feb 15, 2018 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04009421
Coronary Artery Plaque Burden in Stable Angina and Non-obstructive Coronary Artery Disease
N/AActive, not recruiting
1,400 participants
Started: Feb 15, 2018 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT03441061
Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
PHASE2Active, not recruiting
40 participants
Started: Feb 15, 2018 · Completed: Feb 28, 2027
3 conditions2 sponsors1 location
NCT03741582
Urban Transformations and Health: the Case of TransMiCable in Bogotá
N/AActive, not recruiting
2,052 participants
Started: Feb 15, 2018 · Completed: Jun 1, 2025
6 conditions4 sponsors1 location
NCT03217422
ADCC Mediated B-Cell dEpletion and BAFF-R Blockade
PHASE2/PHASE3Active, not recruiting
68 participants
Started: Feb 15, 2018 · Completed: Dec 25, 2025
1 condition1 sponsor28 locations
NCT03389347
High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
NAActive, not recruiting
40 participants
Started: Feb 14, 2018 · Completed: Dec 19, 2026
3 conditions1 sponsor1 location
NCT03394612
Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children
PHASE2Active, not recruiting
20 participants
Started: Feb 14, 2018 · Completed: Dec 31, 2026
1 condition6 sponsors7 locations
NCT03178617
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
NAActive, not recruiting
214 participants
Started: Feb 14, 2018 · Completed: Nov 28, 2025
4 conditions2 sponsors3 locations
NCT03467191
Behavioral Alcohol Responses (BAR) Study
EARLY_PHASE1Active, not recruiting
782 participants
Started: Feb 13, 2018 · Completed: Oct 31, 2025
6 conditions4 sponsors1 location
NCT03282656
Gene Transfer for Sickle Cell Disease
PHASE1Active, not recruiting
10 participants
Started: Feb 13, 2018 · Completed: Dec 13, 2024
1 condition1 sponsor2 locations
NCT03445936
PRELOOP Trial: Synthetic Versus Biological Mesh for Prevention of Incisional Hernia After Loop-ileostomy Closure
NAActive, not recruiting
100 participants
Started: Feb 13, 2018 · Completed: Oct 31, 2027
1 condition1 sponsor4 locations
NCT03217786
Early Post Transplant Cardiac Allograft Vasculopathy
N/AActive, not recruiting
80 participants
Started: Feb 12, 2018 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03413800
Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant
PHASE2Active, not recruiting
10 participants
Started: Feb 12, 2018 · Completed: Jan 1, 2026
2 conditions3 sponsors1 location
NCT03029403
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
PHASE2Active, not recruiting
47 participants
Started: Feb 12, 2018 · Completed: Apr 12, 2026
4 conditions3 sponsors1 location
NCT03400332
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
PHASE1/PHASE2Active, not recruiting
281 participants
Started: Feb 12, 2018 · Completed: Nov 30, 2025
2 conditions1 sponsor72 locations
NCT03437681
Tissue-specific Effects of Insufficient Sleep
NAActive, not recruiting
18 participants
Started: Feb 12, 2018 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT03225547
Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer
PHASE2Active, not recruiting
74 participants
Started: Feb 12, 2018 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT04481087
Clinical Comparison of Different Adhesives in NCCLs
NAActive, not recruiting
34 participants
Started: Feb 10, 2018 · Completed: Jun 10, 2026
1 condition1 sponsor1 location
NCT03319485
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease
NAActive, not recruiting
92 participants
Started: Feb 9, 2018 · Completed: Jan 31, 2025
1 condition1 sponsor20 locations
NCT03423199
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
PHASE3Active, not recruiting
180 participants
Started: Feb 9, 2018 · Completed: Sep 30, 2025
1 condition3 sponsors23 locations
NCT03301441
Sensitivity to Acute Cerebral Ischemia in Migrainers
N/AActive, not recruiting
605 participants
Started: Feb 9, 2018 · Completed: Jul 31, 2024
3 conditions1 sponsor1 location
NCT03410875
A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia
PHASE2Active, not recruiting
30 participants
Started: Feb 9, 2018 · Completed: Jan 31, 2026
3 conditions3 sponsors9 locations
NCT03147612
Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
PHASE2Active, not recruiting
22 participants
Started: Feb 8, 2018 · Completed: Feb 28, 2027
6 conditions1 sponsor1 location